Shuttle Pharmaceuticals Holdings (SHPH) Receivables - Other (2023 - 2024)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Receivables - Other came in at $4.0 in Q3 2024, down 99.97% year-on-year from $12435.0 in Q4 2023, and down 99.94% quarter-over-quarter from $7226.0 in Q2 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Receivables - Other (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Receivables - Other history runs 2 years deep, the most recent figure standing at $4.0 for Q3 2024.
- On a quarterly basis, Receivables - Other fell 99.97% year-over-year to $4.0 in Q3 2024; TTM through Sep 2024 was $4.0, a 99.97% decrease from a year earlier, with the FY2023 full-year figure at $14901.0, changed N/A from the prior year.
- Receivables - Other eased to $4.0 in Q3 2024 per SHPH's latest filing, from $7226.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $14901.0 in Q4 2023 and bottomed at $4.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 4.00 |
| Sep 30, 2024 | 4.00 |
| Jun 30, 2024 | 7,226.00 |
| Jun 30, 2024 | 7,226.00 |
| Mar 31, 2024 | 11,964.00 |
| Mar 31, 2024 | 11,964.00 |
| Dec 31, 2023 | 14,901.00 |
| Dec 31, 2023 | 14,901.00 |
| Sep 30, 2023 | 12,435.00 |
| Sep 30, 2023 | 12,435.00 |
| Jun 30, 2023 | 6,950.00 |
| Jun 30, 2023 | 6,950.00 |
| Mar 31, 2023 | 7,023.00 |
| Mar 31, 2023 | 7,023.00 |